title: Use of biologics for pustulotic arthro-osteitis in two patients with palmoplantar pustulosis.
authors.affiliation: Department of Dermatology, Fukushima Medical University, Fukushima, Japan.
authors.forename: Takenobu
authors.initials: T
authors.lastname: Ohashi
authors.affiliation: Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University, Fukushima, Japan.
authors.forename: Yuko
authors.initials: Y
authors.lastname: Suzuki
authors.affiliation: Department of Dermatology, Fukushima Medical University, Fukushima, Japan.
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Yamamoto
mesh_terms: D000068879:Adalimumab / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D001688:Biological Products / Q000008:administration & dosage / Q000627:therapeutic use*; D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology; D005260:Female; D005384:Finger Joint / Q000000981:diagnostic imaging; D006801:Humans; D000069285:Infliximab / Q000008:administration & dosage / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D010000:Osteitis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D011565:Psoriasis / Q000150:complications* / Q000188:drug therapy; D011877:Radionuclide Imaging; D012867:Skin / Q000473:pathology; D013249:Sternum / Q000000981:diagnostic imaging; D013667:Technetium / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products; C000612965:betamethasone butyrate propionate; D013667:Technetium; D001623:Betamethasone; D000069285:Infliximab; D000068879:Adalimumab